REMOTE CARDIOVASCULAR MONITORING IN POST-TAVI PATIENTS (TELE-TAVI)
Research type
Research Study
Full title
Remote Acute Monitoring-based Same-day Discharge Strategy of Post Transcatheter Aortic Valve Implantation Patients Versus Standard Care at 30-Day Follow-up (TELE-TAVI Trial).
IRAS ID
332448
Contact name
Ramzi Khamis
Contact email
Sponsor organisation
Imperial College London
Duration of Study in the UK
4 years, 0 months, 0 days
Research summary
Aortic stenosis (AS) is a common heart valve disease in Europe and North America, occurring when the aortic valve becomes calcified and narrow. With the increasing number of elderly people, the prevalence of AS is expected to rise. Currently, there is no effective medical therapy for AS; however, interventional therapies like surgery and transcatheter aortic valve implantation (TAVI) are widely performed. TAVI, a minimally invasive procedure often performed with local anesthesia through a transfemoral approach, has become popular, resulting in a shorter hospital length of stay (LOS) and improved recovery compared to traditional surgery. Nevertheless, some patients may develop heart rhythm abnormalities after TAVI.
Advancements in technology-enabled patient care and monitoring offer opportunities to enhance postprocedural outcomes, reducing complications, hospital LOS, costs, the risk of hospital-acquired infections, and the psychological burden associated with prolonged hospital stays. Therefore, a trend toward shorter hospital LOS following TAVI procedures is desirable. One significant concern after TAVI is the development of heart conduction abnormalities on the ECG and abnormal rhythms, such as heart block, potentially requiring permanent pacemaker insertion. Addressing rhythm issues is crucial for attempting to reduce the overall length of stay.
In this project, we propose utilizing a remote monitoring algorithm to gather essential clinical data, aiming to guide the management of post-TAVI patients and reduce both the initial hospital length of stay and readmissions. This strategic integration of technology aims to address gaps identified in previous studies and enhance the effectiveness of post-TAVI patient care.
REC name
London - Chelsea Research Ethics Committee
REC reference
24/LO/0432
Date of REC Opinion
29 Aug 2024
REC opinion
Further Information Favourable Opinion